HTML Microdata document

This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
rdfs	http://www.w3.org/2000/01/rdf-schema#
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
owl	http://www.w3.org/2002/07/owl#
nci	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
xsdh	http://www.w3.org/2001/XMLSchema#

Statements

Subject Item: nci:C2622
rdf:type: owl:Class
rdfs:label: Carcinoembryonic Antigen Peptide 1-6D
rdfs:subClassOf: nci:C49272 _:vb654112 _:vb654113 _:vb654114 _:vb654115
nci:A7: nci:C25159
nci:P106: Amino Acid, Peptide, or Protein Pharmacologic Substance
nci:P108: Carcinoembryonic Antigen Peptide 1-6D
nci:P175: 701524
nci:P207: C0935801
nci:P303: HLA-A2 positive patients with CEA-producing adenocarcinomas of the gastrointestinal tract origin and refractory stage IV CEA-expressing malignancies.
nci:P329: 38236
nci:P330: 38236
nci:P366: CEA_571-579_Peptide
nci:P90: <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Carcinoembryonic Antigen Peptide 1-6D</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Modified CEA Peptide</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>mCEA Peptide</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Carcinoembryonic Antigen Peptide 1-6D</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>CAP-1-6D Peptide</n0:term-name><n0:term-group>AB</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>CEA:571-579 (576D)</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
nci:P97: <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:code: C2622

Subject Item: _:vb654112
rdf:type: owl:Restriction
owl:onProperty: nci:R124
owl:someValuesFrom: nci:C45548

Subject Item: _:vb654113
rdf:type: owl:Restriction
owl:onProperty: nci:R125
owl:someValuesFrom: nci:C19053

Subject Item: _:vb654114
rdf:type: owl:Restriction
owl:onProperty: nci:R72
owl:someValuesFrom: nci:C12543

Subject Item: _:vb654115
rdf:type: owl:Restriction
owl:onProperty: nci:R125
owl:someValuesFrom: nci:C40912